Stock Events

Stock Events

Zhengye Biotechnology 

$1.3100
10
-$0.08-5.76% 01:22 Today

Statistics

Day High
1.31
Day Low
1.31
52W High
3.62
52W Low
0.6146
Volume
1
Avg. Volume
-
Mkt Cap
62.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-60.29%Profit Margin
Unprofitable
2021
2022
2023
2024
2025
16.42MRevenue
-9.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZYBT.BOATS. It's not an investment recommendation.
Vanguard S&P 500
2
VOO
Coca-Cola
2
KO
Invesco QQQ Trust Series 1
2
QQQ
Solana
2
SOL.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
Show More
CEO
ISIN
KYG989MS1016

Listings

XNAS
US
ZYBT
BOATS
BOATS
ZYBT.BOATS

0 Comments

Share your thoughts

FAQs

What is Zhengye Biotechnology stock price today?▼
The current price of ZYBT.BOATS is $1.31 USD — it has decreased by -5.76% in the past 24 hours. Watch Zhengye Biotechnology stock price performance more closely on the chart.
What is Zhengye Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Zhengye Biotechnology stocks are traded under the ticker ZYBT.BOATS.
What is Zhengye Biotechnology market cap?▼
Today Zhengye Biotechnology has the market capitalization of 62.08M
What is Zhengye Biotechnology revenue for the last year?▼
Zhengye Biotechnology revenue for the last year amounts to 16.42M USD.
What is Zhengye Biotechnology net income for the last year?▼
ZYBT.BOATS net income for the last year is -9.9M USD.
In which sector is Zhengye Biotechnology located?▼
Zhengye Biotechnology operates in the Other sector.
When did Zhengye Biotechnology complete a stock split?▼
Zhengye Biotechnology has not had any recent stock splits.